Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2020-06-01
- Lead Sponsor
- Belx Bio-Pharmaceutical (Taiwan) Corporation
- Target Recruit Count
- 23
- Registration Number
- NCT03256331
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
News
No news found